Aurora Financial Journal

Camurus (CAMX.ST)

Nasdaq Stockholm · Pharmaceutical industry · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Camurus reported revenue of SEK 1.87B and net income of SEK 428.4M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

SEKFY2024
2024-12-31
FY2023
2023-12-31
FY2022
2022-12-31
FY2021
2021-12-31
FY2020
2020-12-31
Income statement
RevenueSEK 1.87BSEK 1.72BSEK 956.3MSEK 600.6MSEK 336.0M
Gross profitSEK 1.74BSEK 1.59BSEK 853.1MSEK 515.2MSEK 300.7M
Operating incomeSEK 469.2MSEK 525.9MSEK 72.0M−SEK 110.6M−SEK 205.2M
Net incomeSEK 428.4MSEK 431.4MSEK 55.6M−SEK 90.4M−SEK 167.3M
Diluted EPSSEK 7.20SEK 7.50SEK 0.97−SEK 1.66−SEK 3.18
Cash flow
Operating cash flowSEK 388.0MSEK 606.9MSEK 101.2M−SEK 143.4M−SEK 238.8M
Capital expenditureSEK 27.6MSEK 9.2MSEK 1.9MSEK 4.0MSEK 968.0K
Free cash flowSEK 360.4MSEK 597.7MSEK 99.3M−SEK 147.4M−SEK 239.8M
Balance sheet
Cash and equivalentsSEK 2.85BSEK 1.19BSEK 565.5MSEK 411.6MSEK 461.8M
Total assetsSEK 3.76BSEK 1.91BSEK 1.31BSEK 1.08BSEK 1.04B
Total liabilitiesSEK 467.3MSEK 414.8MSEK 310.8M––
Shareholders' equitySEK 3.29BSEK 1.49BSEK 994.7MSEK 848.9MSEK 847.4M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full CAMX.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open CAMX.ST financials →